home All News open_in_new Full Article

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio

AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies (Europe) B.V. (“IPA Europe”), to AVS Bio for a total enterprise value of $12 million USD. AVS Bio, a portfolio company […]


today 9 d. ago attach_file Events

attach_file Events
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Events
attach_file Society


ID: 3605455751
Add Watch Country

arrow_drop_down